BAF2425

antibody from Novus Biologicals

Targeting: LILRB4 CD85k, HM18, ILT3, LIR-5, LIR5

Western blot (Data presented on provider website)

Flow cytometry (Data presented on provider website)

Antibody Data

Product number

BAF2425

Provider

Novus Biologicals

Product name

Goat Polyclonal ILT3/CD85k/LILRB4 Antibody

Antibody type

Polyclonal

Description

Antigen Affinity-purified. Detects human LILRB4/CD85k/ILT3 in Western blots. In Western blots, approximately 10% cross-reactivity with recombinant human (rh) ILT4 and rhILT5 and 5% cross-reactivity with rhILT2 is observed.

Reactivity

Human

Host

Goat

Conjugate

Biotin

Isotype

IgG

Vial size

50 ug

Concentration

LYOPH

Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

References

Submitted references

Interferon beta and vitamin D synergize to induce immunoregulatory receptors on peripheral blood monocytes of multiple sclerosis patients.

Waschbisch A, Sanderson N, Krumbholz M, Vlad G, Theil D, Schwab S, Mäurer M, Derfuss T
PloS one 2014;9(12):e115488

---

Cytokine induced expression of programmed death ligands in human neutrophils.

Bankey PE, Banerjee S, Zucchiatti A, De M, Sleem RW, Lin CF, Miller-Graziano CL, De AK
Immunology letters 2010 Apr 8;129(2):100-7

---

Inhibitory immunoglobulin-like receptors LILRB and PIR-B negatively regulate osteoclast development.

Mori Y, Tsuji S, Inui M, Sakamoto Y, Endo S, Ito Y, Fujimura S, Koga T, Nakamura A, Takayanagi H, Itoi E, Takai T
Journal of immunology (Baltimore, Md. : 1950) 2008 Oct 1;181(7):4742-51

---

Inhibitory immunoglobulin-like receptors LILRB and PIR-B negatively regulate osteoclast development.

Mori Y, Tsuji S, Inui M, Sakamoto Y, Endo S, Ito Y, Fujimura S, Koga T, Nakamura A, Takayanagi H, Itoi E, Takai T
Journal of immunology (Baltimore, Md. : 1950) 2008 Oct 1;181(7):4742-51

---

Soluble Ig-like transcript 3 inhibits tumor allograft rejection in humanized SCID mice and T cell responses in cancer patients.

Suciu-Foca N, Feirt N, Zhang QY, Vlad G, Liu Z, Lin H, Chang CC, Ho EK, Colovai AI, Kaufman H, D'Agati VD, Thaker HM, Remotti H, Galluzzo S, Cinti P, Rabitti C, Allendorf J, Chabot J, Caricato M, Coppola R, Berloco P, Cortesini R
Journal of immunology (Baltimore, Md. : 1950) 2007 Jun 1;178(11):7432-41

---

Soluble Ig-like transcript 3 inhibits tumor allograft rejection in humanized SCID mice and T cell responses in cancer patients.

Suciu-Foca N, Feirt N, Zhang QY, Vlad G, Liu Z, Lin H, Chang CC, Ho EK, Colovai AI, Kaufman H, D'Agati VD, Thaker HM, Remotti H, Galluzzo S, Cinti P, Rabitti C, Allendorf J, Chabot J, Caricato M, Coppola R, Berloco P, Cortesini R
Journal of immunology (Baltimore, Md. : 1950) 2007 Jun 1;178(11):7432-41